Zobrazeno 1 - 7
of 7
pro vyhledávání: '"M G, Sanda"'
Autor:
C, Hwang, M G, Sanda
Publikováno v:
Current opinion in molecular therapeutics. 1(4)
Prostate cancer is a disease that may be amenable to immunotherapy approaches, as evidenced by the ability to induce human cytotoxic immune responses against prostate cancer cells. Recent interest in recombinant poxvirus vaccines coupled with the nee
Publikováno v:
Cancer research. 61(2)
An essential event in the progression of adenocarcinoma is the loss of organized epithelial attachment (both to the basement membrane and to adjoining epithelial cells). The E-cadherin cell adhesion molecule has an established function in maintaining
Publikováno v:
The Journal of urology. 163(1)
We determine the clinical efficacy of endoscopically injected collagen for the treatment of new onset urinary incontinence in women following cystectomy and orthotopic neobladder.Three women 58 to 74 years old underwent transurethral collagen injecti
Autor:
J W, Simons, B, Mikhak, J F, Chang, A M, DeMarzo, M A, Carducci, M, Lim, C E, Weber, A A, Baccala, M A, Goemann, S M, Clift, D G, Ando, H I, Levitsky, L K, Cohen, M G, Sanda, R C, Mulligan, A W, Partin, H B, Carter, S, Piantadosi, F F, Marshall, W G, Nelson
Publikováno v:
Cancer research. 59(20)
Vaccination with irradiated granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting gene-transduced cancer vaccines induces tumoricidal immune responses. In a Phase I human gene therapy trial, eight immunocompetent prostate cancer (PCA) p
Autor:
C X, Hsu, B D, Ross, C E, Chrisp, S Z, Derrow, L G, Charles, K J, Pienta, N M, Greenberg, Z, Zeng, M G, Sanda
Publikováno v:
The Journal of urology. 160(4)
Human prostate cancer is variably lethal, shows heterogeneous progression, and exhibits a spectrum of histopathology. Traditional rodent models of prostate cancer lack these characteristics. An alternative, autochthonous model of prostate cancer cons
Autor:
M G, Sanda
Publikováno v:
Seminars in urologic oncology. 15(1)
Several clinical trials of prostate cancer gene therapy are underway. The therapeutic genes being evaluated by these and other, forthcoming, trials include immunogenes, cell death-inducing genes, antioncogenes, and tumor suppressor genes. Constraints
Publikováno v:
Transplantation proceedings. 21(1 Pt 3)